manufacturing agreement IdentifySensors Biologics, East West Manufacturing Partner on Rapid Saliva-Based Biosensor MDx The firm's rapid technology uses saliva samples and graphene-based inks printed onto solid-state electronics to differentiate infectious diseases. Singapore's Mirxes Inks Agreements for Cancer Early Detection Tests in China, Indonesia Mirxes signed an MOU to scale up manufacturing of its tests in China and expanded an existing commercialization partnership in Indonesia. IdentifySensors Biologics, Jabil Partner to Manufacture Digital Diagnostic Platform The companies will manufacture the Check4 device, which electronically identifies the genetic material of target pathogens. DnaNudge Signs Manufacturing Deal for Coronavirus Test Component With Jabil Healthcare The test, called CovidNudge, is a version of DnaNudge's consumer DNA test that has been reengineered for the point-of-care detection of SARS-CoV-2. DnaNudge, Benchmark Electronics Ink Manufacturing Deal for Rapid Molecular Coronavirus Kit In August, the UK government announced a 5.8 million order for DnaNudge's COVID-19 test kits to enable their rollout in UK NHS hospitals and out-of-hospital locations. Jun 8, 2020 Sherlock Biosciences, IDT Collaborate to Manufacture CRISPR-Based SARS-CoV-2 Testing Kits Jun 2, 2020 Codexis, Alphazyme Ink Comarketing, Production Agreement for Enzymes Apr 14, 2020 Co-Diagnostics, Promega Ink Manufacturing Deal for Coronavirus Test Mar 25, 2020 Yourgene Health to Manufacture Coronavirus Test for Novacyt Mar 2, 2020 RevoluGen, GE Healthcare Life Sciences Ink DNA Extraction Product Manufacturing Deal Feb 24, 2020 BioSkryb Signs Contract Production Deal With Argonaut Manufacturing Jan 22, 2020 Rapid Labs Inks Manufacturing, Supply Deal for RNAssist Sample Prep Products Nov 6, 2018 Vortex Biosciences, Stratec Consumables Strike Supply Agreement Dec 12, 2017 Aldevron to Manufacture, Distribute IDT-Patented Cas9 Variant Aug 15, 2017 Cambridge Epigenetix, NuGen Form Epigenetic Sequencing Partnership Oct 19, 2015 Sigma-Aldrich Inks Deal to Manufacture, Distribute Sanger Institute's CRISPR Knock-Out Libraries Sep 10, 2014 Plexus to Commercially Manufacture Microsaic's Miniature Mass Spectrometer Apr 15, 2014 Biocartis, Invetech Ink Deal Covering Biomarker Analysis Platform Mar 6, 2014 NEB, Lumora Ink Manufacturing, Supply Deal Jan 20, 2014 Trinean to Manufacture Qiagen's Microvolume Spectrometer Mar 2, 2012 Rubicon Genomics Selects Velesco to Manufacture Kits Jul 20, 2011 Quanterix, Sony DADC to Develop and Manufacture Consumables for SiMoA Platform May 3, 2011 Atossa Genetics, HLB Sign Manufacturing Deal Mar 21, 2011 Quanta, IDT Sign Deal for Manufacture of microRNA Assays Feb 7, 2011 Consort Medical Takes Nearly 20 Percent Stake in Atlas Genetics Load More Breaking News GenomeWeb Top 40 Down 10 Percent in September, Outpacing Decline in Broader Market Natera Submits Signatera Bladder Cancer PMA Module to FDA FDA Grants Emergency Use Authorizations for POC COVID Tests from Tangen Biosciences, SD Biosensor Top Five Articles on GenomeWeb Last Week: FDA Proposal for LDT Oversight, Adela $48M Financing, More FDA Grants Marketing Authorization for Invitae Hereditary Cancer DNA Sequencing Test The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.